Peripheral decarboxylase inhibitors paradoxically induce aromatic L-amino acid decarboxylase
Abstract Peripheral decarboxylase inhibitors (PDIs) prevent conversion of levodopa to dopamine in the blood by the enzyme aromatic L-amino acid decarboxylase (AADC). Alterations in enzyme activity may contribute to the required higher dosages of levodopa observed in many patients with Parkinson’s di...
Main Authors: | Anouke van Rumund, Lukas Pavelka, Rianne A. J. Esselink, Ben P. M. Geurtz, Ron A. Wevers, Brit Mollenhauer, Rejko Krüger, Bastiaan R. Bloem, Marcel M. Verbeek |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-03-01
|
Series: | npj Parkinson's Disease |
Online Access: | https://doi.org/10.1038/s41531-021-00172-z |
Similar Items
-
Aromatic l‐amino acid decarboxylase deficiency in Taiwan
by: Wuh‐Liang Hwu, et al.
Published: (2023-09-01) -
Aromatic L-Amino acid decarboxylase deficiency: A new case from Turkey with a novel mutation
by: Kivilcim Gucuyener, et al.
Published: (2014-01-01) -
Aromatic Amino Acid Decarboxylase Deficiency: The Added Value of Biochemistry
by: Riccardo Montioli, et al.
Published: (2021-03-01) -
Family case of aromatic L-amino acid decarboxylase deficiency
by: O. B. Kondakova, et al.
Published: (2022-12-01) -
Upregulation of the Aromatic Amino Acid Decarboxylase under Neonatal Asphyxia
by: Peter Brust, et al.
Published: (1999-04-01)